ERBB2 and neoplasm: Immunohistochemistry confirmed Estrogen Receptor (ER) weakly positive (20%), Progesterone Receptor (PR)-negative, Androgen Receptor (AR) weakly positive (10%), Her-2 (0), mutant P53-positive (90%), Ki-67 positive (80%) tumor.